These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7752299)

  • 1. Disposition of creatine kinase activity in dog plasma following intravenous and intramuscular injection of skeletal muscle homogenates.
    Aktas M; Lefebvre HP; Toutain PL; Braun JP
    J Vet Pharmacol Ther; 1995 Feb; 18(1):1-6. PubMed ID: 7752299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive and quantitative evaluation of post-injection muscle damage by pharmacokinetic analysis of creatine kinase release.
    Lefebvre HP; Laroute V; Braun JP; Lassourd V; Toutain PL
    Vet Res; 1996; 27(4-5):343-61. PubMed ID: 8822606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bioavailability of muscle creatine kinase in sheep. Application to the assessment of local tolerance to injectable veterinary formulations].
    Verlinde V; Mikaelian I; Laurentie M; Sanders P; Poul JM
    Vet Res; 1996; 27(2):133-46. PubMed ID: 8721293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses.
    Toutain PL; Lassourd V; Costes G; Alvinerie M; Bret L; Lefebvre HP; Braun JP
    J Vet Pharmacol Ther; 1995 Jun; 18(3):226-35. PubMed ID: 7674460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compared kinetics of plasma creatine kinase activity in rabbits after intravenous injection of different preparations of skeletal muscle.
    Lefebvre HP; Toutain PL; Bret L; Rico AG; Braun JP
    Vet Res; 1993; 24(6):468-76. PubMed ID: 8111429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo non-invasive quantification of muscle damage following a single intramuscular injection of phenylbutazone in sheep.
    Houpert P; Serthelon JP; Lefebvre HP; Toutain PL; Braun JP
    Vet Hum Toxicol; 1995 Apr; 37(2):105-10. PubMed ID: 7631487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of plasma creatine kinase pharmacokinetics to estimate the amount of excercise-induced muscle damage in Beagles.
    Chanoit GP; Lefebvre HP; Orcel K; Laroute V; Toutain PL; Braun JP
    Am J Vet Res; 2001 Sep; 62(9):1375-80. PubMed ID: 11560263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic variables and bioavailability from muscle of creatine kinase in cattle.
    Lefebvre HP; Toutain PL; Serthelon JP; Lassourd V; Gardey L; Braun JP
    Am J Vet Res; 1994 Apr; 55(4):487-93. PubMed ID: 8017694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic evaluation of intramuscular artesunate in healthy beagle dogs.
    Bennett K; Si Y; Steinbach T; Zhang J; Li Q
    Am J Trop Med Hyg; 2008 Jul; 79(1):36-41. PubMed ID: 18606761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic evaluation of muscle damage during exercise by calculation of amount of creatine kinase released.
    Volfinger L; Lassourd V; Michaux JM; Braun JP; Toutain PL
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R434-41. PubMed ID: 8141400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous and minimally invasive assessment of muscle tolerance and bioavailability of different volumes of an intramuscular formulation in the same animals.
    Ferre PJ; Laroute V; Braun JP; Cazaux J; Toutain PL; Lefebvre HP
    J Anim Sci; 2006 May; 84(5):1295-301. PubMed ID: 16612034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatine kinase in the dog: a review.
    Aktas M; Auguste D; Lefebvre HP; Toutain PL; Braun JP
    Vet Res Commun; 1993; 17(5):353-69. PubMed ID: 8209415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration.
    Kaartinen L; Panu S; Pyörälä S
    Equine Vet J; 1997 Sep; 29(5):378-81. PubMed ID: 9306065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma enzyme activity after intramuscular injection of bupivacaine into the human biceps brachii.
    Nosaka K; Sakamoto K
    Acta Physiol Scand; 1999 Nov; 167(3):259-65. PubMed ID: 10606828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of serum creatine kinase activity.
    Carlson CJ; Meister W; Emilson B; Sheiner LB; Rapaport E
    Cardiovasc Res; 1982 Feb; 16(2):66-70. PubMed ID: 7074667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and preliminary observations of behavioral changes following administration of midazolam to dogs.
    Court MH; Greenblatt DJ
    J Vet Pharmacol Ther; 1992 Dec; 15(4):343-50. PubMed ID: 1487833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of tildipirosin in horses after intravenous and intramuscular administration and its potential muscle damage.
    Galecio JS; Escudero E; Badillo E; Marín P
    Res Vet Sci; 2022 Dec; 152():20-25. PubMed ID: 35908422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of danofloxacin in horses after intravenous, intramuscular and intragastric administration.
    Fernández-Varón E; Ayala I; Marín P; Carrión A; Martos N; Escudero E; Cárceles CM
    Equine Vet J; 2006 Jul; 38(4):342-6. PubMed ID: 16866202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increase of blood levels of creatine kinase following intramuscular injection].
    Montero Pérez FJ; Muñoz Avila J; Berlango Jiménez A; Durán Serantes M; Calderón de la Barca Vázquez JM; Jiménez Murillo L; Torres Murillo J
    Med Clin (Barc); 1996 Nov; 107(17):649-54. PubMed ID: 9064405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.